target mouse p815 plasmacytoma cells (ATCC)
Structured Review
![FIGURE 3 – CTL response in Ad5-HER2-immunized mice. (a) Spleen cells from BALB/c mice vaccinated with Ad5-HER2 were restimulated in vitro with HER2-15 or HER2-301 peptides and tested for cytotoxic activity against <t>P815</t> target cells pulsed with the same peptides. As negative control, HER2-15- or HER2-301-restimulated spleen cells were tested on DMSO-pulsed P815 target cells. Average values are reported. (b) Spleen cells from neuT mice vaccinated with Ad5-HER2 were restimulated in vitro with HER2-15.3, neu-15.3, or HER2-301 and tested for cytotoxic activity against P815 target cells pulsed with the same peptides or DMSO (negative control). Spleen cells restimulated by infection with recombinant vaccinia virus ex- pressing r-p185 protein (vv-neu) were tested on target cells pulsed with neu-15.3 peptide or DMSO (negative control). Spleen cells from nonvaccinated mice reproducibly yielded background values of counts. The percentage of specific lysis was calculated by using the following formula: % specific lysis 100 [(experimental release spontaneous release)/(maximum release spontaneous release)], where the spontaneous and maximum release refer to the number of counts in DMSO or in 1% Triton X-100 target cell lysate, respectively. Effector cell/target cell ratios are indicated in the abscissa. The per- centage of specific killing is reported on the vertical axis. Average value of negative controls is displayed. Reported data are representa- tive of several independent experiments.](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_6429/pm15386429/pm15386429__page7_image1.jpg)
Target Mouse P815 Plasmacytoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1036 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p815+plasmacytoma/P815/pm15386429-22-4-13
Average 96 stars, based on 1036 article reviews
Images
1) Product Images from "Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector."
Article Title: Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.
Journal: International journal of cancer
doi: 10.1002/ijc.20536
Figure Legend Snippet: FIGURE 3 – CTL response in Ad5-HER2-immunized mice. (a) Spleen cells from BALB/c mice vaccinated with Ad5-HER2 were restimulated in vitro with HER2-15 or HER2-301 peptides and tested for cytotoxic activity against P815 target cells pulsed with the same peptides. As negative control, HER2-15- or HER2-301-restimulated spleen cells were tested on DMSO-pulsed P815 target cells. Average values are reported. (b) Spleen cells from neuT mice vaccinated with Ad5-HER2 were restimulated in vitro with HER2-15.3, neu-15.3, or HER2-301 and tested for cytotoxic activity against P815 target cells pulsed with the same peptides or DMSO (negative control). Spleen cells restimulated by infection with recombinant vaccinia virus ex- pressing r-p185 protein (vv-neu) were tested on target cells pulsed with neu-15.3 peptide or DMSO (negative control). Spleen cells from nonvaccinated mice reproducibly yielded background values of counts. The percentage of specific lysis was calculated by using the following formula: % specific lysis 100 [(experimental release spontaneous release)/(maximum release spontaneous release)], where the spontaneous and maximum release refer to the number of counts in DMSO or in 1% Triton X-100 target cell lysate, respectively. Effector cell/target cell ratios are indicated in the abscissa. The per- centage of specific killing is reported on the vertical axis. Average value of negative controls is displayed. Reported data are representa- tive of several independent experiments.
Techniques Used: In Vitro, Activity Assay, Negative Control, Infection, Recombinant, Virus, Lysis
Related Articles
Derivative Assay:Article Title: Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8+ and CD4+ T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity Article Snippet: .. The P815 plasmacytoma derived from |

